
Bioventus (BVS) Stock Forecast & Price Target
Bioventus (BVS) Analyst Ratings
Bulls say
Bioventus is set to make significant strides in the medical device market as they have shown strong financial performance and have provided bullish financial guidance for the future. Their focus on building their PNS and PRP businesses, along with international expansion and investment in growth drivers, gives the company a solid foundation for growth. With a strong balance sheet, solid cash flow generation, and promising valuation metrics, Bioventus is positioned for success and we recommend considering investment in the company's shares.
Bears say
Bioventus is facing a decline in revenue in their restorative therapies segment, which is primarily due to the recent divestiture of the Advanced Rehab business. The company plans to invest in their ultrasonics business to drive growth through sales expansion and medical education. However, potential growth may be limited as the company expects only low single digit growth in the restorative therapies segment in 2026.
This aggregate rating is based on analysts' research of Bioventus and is not a guaranteed prediction by Public.com or investment advice.
Bioventus (BVS) Analyst Forecast & Price Prediction
Start investing in Bioventus (BVS)
Order type
Buy in
Order amount
Est. shares
0 shares